Key result
Intra-myocardial growth hormone administration lowered the arrhythmia score and preserved electrical conduction compared to controls in 33 rats 2 weeks post-myocardial infarction.
Why the study?
Does intra-myocardial growth hormone administration improve electrophysiologic remodeling and reduce induced tachyarrhythmias in rats post-myocardial infarction?
Does intra-myocardial growth hormone administration improve electrophysiologic remodeling and reduce induced tachyarrhythmias in rats post-myocardial infarction?
Intra-myocardial growth hormone administration post-infarction in rats preserves electrical conduction and reduces the incidence of induced tachyarrhythmias.
Experimental studies indicate improved ventricular function after treatment with growth hormone (GH) post-myocardial infarction, but its effect on arrhythmogenesis is unknown. Here, we assessed the medium-term electrophysiologic remodeling after intra-myocardial GH administration in (n = 33) rats. GH was released from an alginate scaffold, injected around the ischemic myocardium after coronary ligation. Two weeks thereafter, ventricular tachyarrhythmias were induced by programmed electrical stimulation. Monophasic action potentials were recorded from the infarct border, coupled with evaluation of electrical conduction and repolarization from a multi-electrode array. The arrhythmia score was lower in GH-treated rats than in alginate-treated rats or controls. The shape and the duration of the action potential at the infarct border were preserved, and repolarization-dispersion was attenuated after GH; moreover, voltage rise was higher and activation delay was shorter. GH normalized also right ventricular parameters. Intra-myocardial GH preserved electrical conduction and repolarization-dispersion at the infarct border and decreased the incidence of induced tachyarrhythmias in rats post-ligation. The long-term antiarrhythmic potential of GH merits further study.
No takes yet. Share an insight, caveat, or question.
Kontonika et al. (2017) studied Myocardial infarction (n=33). Intra-myocardial growth hormone vs. Alginate scaffold alone or controls was evaluated on Arrhythmia score and electrophysiologic remodeling. Intra-myocardial growth hormone administration lowered the arrhythmia score and preserved electrical conduction compared to controls in 33 rats 2 weeks post-myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: